PT100417A - Formas de dosagem de farmacos compreendendo polimeros com diferentes massas moleculares - Google Patents

Formas de dosagem de farmacos compreendendo polimeros com diferentes massas moleculares

Info

Publication number
PT100417A
PT100417A PT100417A PT10041792A PT100417A PT 100417 A PT100417 A PT 100417A PT 100417 A PT100417 A PT 100417A PT 10041792 A PT10041792 A PT 10041792A PT 100417 A PT100417 A PT 100417A
Authority
PT
Portugal
Prior art keywords
composition
pharmacology
polymers
forms
different molecular
Prior art date
Application number
PT100417A
Other languages
English (en)
Other versions
PT100417B (pt
Inventor
Brian L Barclay
Jeri Dawn Wright
David R Swanson
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Publication of PT100417A publication Critical patent/PT100417A/pt
Publication of PT100417B publication Critical patent/PT100417B/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Polyoxymethylene Polymers And Polymers With Carbon-To-Carbon Bonds (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PT100417A 1991-04-22 1992-04-22 Formas de dosagem de farmacos compreendendo polimeros com diferentes massas moleculares PT100417B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/688,807 US5208037A (en) 1991-04-22 1991-04-22 Dosage forms comprising polymers comprising different molecular weights

Publications (2)

Publication Number Publication Date
PT100417A true PT100417A (pt) 1993-08-31
PT100417B PT100417B (pt) 1999-06-30

Family

ID=24765867

Family Applications (1)

Application Number Title Priority Date Filing Date
PT100417A PT100417B (pt) 1991-04-22 1992-04-22 Formas de dosagem de farmacos compreendendo polimeros com diferentes massas moleculares

Country Status (17)

Country Link
US (2) US5208037A (pt)
EP (1) EP0581862B1 (pt)
JP (1) JP2638303B2 (pt)
KR (1) KR0158466B1 (pt)
AT (1) ATE142481T1 (pt)
AU (1) AU655827B2 (pt)
CA (1) CA2101245C (pt)
DE (1) DE69213729T2 (pt)
ES (1) ES2092115T3 (pt)
FI (1) FI110160B (pt)
IE (1) IE921269A1 (pt)
MX (1) MX9201813A (pt)
NO (1) NO306976B1 (pt)
NZ (1) NZ242419A (pt)
PT (1) PT100417B (pt)
WO (1) WO1992018102A1 (pt)
ZA (1) ZA922907B (pt)

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6764697B1 (en) * 1991-06-27 2004-07-20 Alza Corporation System for delaying drug delivery up to seven hours
HUT75616A (en) * 1992-03-17 1997-05-28 Pfizer Method for prooucing porous delivery devices
US6440457B1 (en) 1993-05-27 2002-08-27 Alza Corporation Method of administering antidepressant dosage form
ZA953078B (en) * 1994-04-28 1996-01-05 Alza Corp Effective therapy for epilepsies
US5914131A (en) * 1994-07-07 1999-06-22 Alza Corporation Hydromorphone therapy
US5529787A (en) * 1994-07-07 1996-06-25 Alza Corporation Hydromorphone therapy
AU2059297A (en) * 1996-03-12 1997-10-01 Alza Corporation Composition and dosage form comprising opioid antagonist
US6919373B1 (en) 1996-11-12 2005-07-19 Alza Corporation Methods and devices for providing prolonged drug therapy
ZA979605B (en) * 1996-11-25 1998-05-21 Alza Corp Ascending-dose dosage form.
WO1998023263A1 (en) * 1996-11-25 1998-06-04 Alza Corporation Ascending-dose dosage form
EP1782798A3 (en) 1996-11-25 2008-05-21 Alza Corporation Ascending-dose dosage form
US20070185032A1 (en) * 1996-12-11 2007-08-09 Praecis Pharmaceuticals, Inc. Pharmaceutical formulations for sustained drug delivery
US5968895A (en) * 1996-12-11 1999-10-19 Praecis Pharmaceuticals, Inc. Pharmaceutical formulations for sustained drug delivery
US5922352A (en) * 1997-01-31 1999-07-13 Andrx Pharmaceuticals, Inc. Once daily calcium channel blocker tablet having a delayed release core
US5837379A (en) * 1997-01-31 1998-11-17 Andrx Pharmaceuticals, Inc. Once daily pharmaceutical tablet having a unitary core
GT199800127A (es) * 1997-08-29 2000-02-01 Combinaciones terapeuticas.
US6485748B1 (en) 1997-12-12 2002-11-26 Andrx Pharmaceuticals, Inc. Once daily pharmaceutical tablet having a unitary core
US6224907B1 (en) * 1998-03-06 2001-05-01 Alza Corporation Anti-asthma therapy
US6524620B2 (en) 1998-07-20 2003-02-25 Andrx Pharmaceuticals, Inc. Diltiazem controlled release formulation and method of manufacture
US7108866B1 (en) 1999-12-10 2006-09-19 Biovall Laboratories International Srl Chronotherapeutic diltiazem formulations and the administration thereof
US20060153914A1 (en) * 1999-12-10 2006-07-13 Biovail Laboratories International S.R.L. Chronotherapeutic diltiazem formulations and the administration thereof
JP2003518487A (ja) 1999-12-23 2003-06-10 ファイザー・プロダクツ・インク ヒドロゲル駆動型積層薬物製剤
KR100736132B1 (ko) 2000-02-04 2007-07-06 알자 코포레이션 삼투적으로 구동되는 액체 디스펜서 및 코팅 조성물
US7838032B2 (en) * 2000-04-28 2010-11-23 Reckitt Benckiser Inc. Sustained release of guaifenesin
US7985420B2 (en) * 2000-04-28 2011-07-26 Reckitt Benckiser Inc. Sustained release of guaifenesin combination drugs
US8012504B2 (en) * 2000-04-28 2011-09-06 Reckitt Benckiser Inc. Sustained release of guaifenesin combination drugs
US6955821B2 (en) 2000-04-28 2005-10-18 Adams Laboratories, Inc. Sustained release formulations of guaifenesin and additional drug ingredients
US6372252B1 (en) 2000-04-28 2002-04-16 Adams Laboratories, Inc. Guaifenesin sustained release formulation and tablets
US20040001886A1 (en) * 2001-10-17 2004-01-01 Dr. Reddy's Laboratories Limited Stabilized pharmaceutical formulations containing amlodipine maleate
US20030185882A1 (en) * 2001-11-06 2003-10-02 Vergez Juan A. Pharmaceutical compositions containing oxybutynin
US8329217B2 (en) 2001-11-06 2012-12-11 Osmotica Kereskedelmi Es Szolgaltato Kft Dual controlled release dosage form
WO2003066041A1 (en) * 2002-02-07 2003-08-14 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Carnitine in the treatment of geriatric depression
US20050272812A1 (en) * 2002-02-07 2005-12-08 Pettegrew Jay W Methor for use of acetyl-L-carnitine (ALCAR) for treatment of depressive disorders in humans
US7407778B2 (en) * 2002-02-07 2008-08-05 Pettegrew Jay W Compounds, compositions and methods for treating neuropsychiatric disorders
US8894973B2 (en) * 2002-02-07 2014-11-25 Jay W. Pettegrew Method and system for differential diagnosis of chronic schizophrenia and chronic alcoholism
US20100010336A1 (en) * 2002-02-07 2010-01-14 Pettegrew Jay W Method and system for diagnosis of neuropsychiatric disorders including attention deficit hyperactivity disorder (adhd), autism, and schizophrenia
US7700074B2 (en) * 2002-02-07 2010-04-20 Pettegrew Jay W Method and system for diagnosis of neuropsychiatric disorders including chronic alcoholism
GB0203296D0 (en) * 2002-02-12 2002-03-27 Glaxo Group Ltd Novel composition
US20040005359A1 (en) * 2002-06-27 2004-01-08 Cheng Xiu Xiu Controlled release oral dosage form
US8637512B2 (en) * 2002-07-29 2014-01-28 Glaxo Group Limited Formulations and method of treatment
US20050232995A1 (en) 2002-07-29 2005-10-20 Yam Nyomi V Methods and dosage forms for controlled delivery of paliperidone and risperidone
WO2004026283A1 (en) 2002-09-20 2004-04-01 Alpharma, Inc. Sequestering subunit and related compositions and metohds
US20060193825A1 (en) * 2003-04-29 2006-08-31 Praecis Phamaceuticals, Inc. Pharmaceutical formulations for sustained drug delivery
US20050112087A1 (en) * 2003-04-29 2005-05-26 Musso Gary F. Pharmaceutical formulations for sustained drug delivery
CA2956645A1 (en) 2003-07-12 2005-03-31 David A. Goldberg Sensitive and rapid biodetection
US20120077206A1 (en) 2003-07-12 2012-03-29 Accelr8 Technology Corporation Rapid Microbial Detection and Antimicrobial Susceptibility Testing
US8158156B2 (en) 2006-06-19 2012-04-17 Alpharma Pharmaceuticals, Llc Abuse-deterrent multi-layer pharmaceutical composition comprising an opioid antagonist and an opioid agonist
CN100563637C (zh) * 2006-10-13 2009-12-02 北京红林制药有限公司 一种控释给药的药芯组合物和控释制剂及其制备方法
CN100563638C (zh) * 2006-10-24 2009-12-02 北京红林制药有限公司 硝苯地平控释片及其制备方法
EP2601935A1 (en) 2007-09-25 2013-06-12 Solubest Ltd. Compositions comprising lipophilic active compounds and method for their preparation
US8623418B2 (en) 2007-12-17 2014-01-07 Alpharma Pharmaceuticals Llc Pharmaceutical composition
WO2012071220A1 (en) * 2010-11-23 2012-05-31 Transcept Pharmaceuticals, Inc. Compositions and methods for once-daily administration of a trilayer osmotic tablet
US9434937B2 (en) 2011-03-07 2016-09-06 Accelerate Diagnostics, Inc. Rapid cell purification systems
US10254204B2 (en) 2011-03-07 2019-04-09 Accelerate Diagnostics, Inc. Membrane-assisted purification
US9677109B2 (en) 2013-03-15 2017-06-13 Accelerate Diagnostics, Inc. Rapid determination of microbial growth and antimicrobial susceptibility
JP7064285B2 (ja) 2013-12-06 2022-05-10 デュレクト コーポレーション 抗酸化剤を含む組成物、流体分注器、及びそれらに関わる方法
US10253355B2 (en) 2015-03-30 2019-04-09 Accelerate Diagnostics, Inc. Instrument and system for rapid microorganism identification and antimicrobial agent susceptibility testing
WO2016161022A2 (en) 2015-03-30 2016-10-06 Accerlate Diagnostics, Inc. Instrument and system for rapid microorganism identification and antimicrobial agent susceptibility testing
CA3001337C (en) 2015-10-09 2023-12-12 Reckitt Benckiser Llc Pharmaceutical formulation

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3845770A (en) * 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US3916899A (en) * 1973-04-25 1975-11-04 Alza Corp Osmotic dispensing device with maximum and minimum sizes for the passageway
US4111202A (en) * 1976-11-22 1978-09-05 Alza Corporation Osmotic system for the controlled and delivery of agent over time
US4327725A (en) * 1980-11-25 1982-05-04 Alza Corporation Osmotic device with hydrogel driving member
US4783337A (en) * 1983-05-11 1988-11-08 Alza Corporation Osmotic system comprising plurality of members for dispensing drug
US4765989A (en) * 1983-05-11 1988-08-23 Alza Corporation Osmotic device for administering certain drugs
NZ206600A (en) * 1983-05-11 1987-01-23 Alza Corp Osmotic drug delivery device
GB2140487B (en) * 1983-05-25 1987-03-11 Baker Ham & Co Ltd Improvements relating to penstocks
US4717566A (en) * 1984-03-19 1988-01-05 Alza Corporation Dosage system and method of using same
US4863456A (en) * 1986-04-30 1989-09-05 Alza Corporation Dosage form with improved delivery capability
US4743248A (en) * 1986-08-11 1988-05-10 Alza Corporation Dosage form for delivering acid sensitive beneficial agent
US4950486A (en) * 1987-10-02 1990-08-21 Alza Corporation Dosage form for treating cardiovascular diseases
US4946687A (en) * 1987-10-02 1990-08-07 Alza Corporation Dosage form for treating cardiovascular diseases
US4816263A (en) * 1987-10-02 1989-03-28 Alza Corporation Dosage form for treating cardiovascular diseases comprising isradipine
US4904474A (en) * 1988-01-25 1990-02-27 Alza Corporation Delivery of drug to colon by oral disage form
US4837111A (en) * 1988-03-21 1989-06-06 Alza Corporation Dosage form for dispensing drug for human therapy
US4859470A (en) * 1988-06-02 1989-08-22 Alza Corporation Dosage form for delivering diltiazem
US4966769A (en) * 1988-06-02 1990-10-30 Alza Corporation Method for delivering dosage form for diltiazem
US4902514A (en) * 1988-07-21 1990-02-20 Alza Corporation Dosage form for administering nilvadipine for treating cardiovascular symptoms
US4948593A (en) * 1989-05-15 1990-08-14 Alza Corporation Osmotic dosage form comprising an estrogen and a progestogen
US5024843A (en) * 1989-09-05 1991-06-18 Alza Corporation Oral hypoglycemic glipizide granulation

Also Published As

Publication number Publication date
AU655827B2 (en) 1995-01-12
KR0158466B1 (ko) 1998-12-01
US5208037A (en) 1993-05-04
ES2092115T3 (es) 1996-11-16
FI934653A0 (fi) 1993-10-21
AU1917392A (en) 1992-11-17
WO1992018102A1 (en) 1992-10-29
DE69213729D1 (de) 1996-10-17
EP0581862A1 (en) 1994-02-09
ZA922907B (en) 1993-02-24
IE921269A1 (en) 1992-11-04
NZ242419A (en) 1994-07-26
DE69213729T2 (de) 1997-01-30
ATE142481T1 (de) 1996-09-15
JPH06506952A (ja) 1994-08-04
CA2101245A1 (en) 1992-10-23
NO933728L (no) 1993-10-18
NO306976B1 (no) 2000-01-24
US5326571A (en) 1994-07-05
PT100417B (pt) 1999-06-30
FI110160B (fi) 2002-12-13
FI934653A (fi) 1993-10-21
MX9201813A (es) 1992-10-01
CA2101245C (en) 2002-06-25
JP2638303B2 (ja) 1997-08-06
EP0581862B1 (en) 1996-09-11

Similar Documents

Publication Publication Date Title
PT100417A (pt) Formas de dosagem de farmacos compreendendo polimeros com diferentes massas moleculares
FI930862A (fi) En doseringsform foer tidsvarierande moenster av laekemedeloeverlaotelse
FI971404A0 (fi) Lääke nivelraumaan sisältäen IL-6-antagonistin aktiivisena aineena
PT735882E (pt) Combinacao contraceptiva contendo antagonistas de progesterona e um progestogeno
HUP9601566A3 (en) Therapeutic tetrahydro-isoquinolin derivatives, their intermediates and pharmaceutical compositions containing the active component
FR2680760B1 (fr) Cartouche pour la distribution integrale de masses pateuses.
TR200201102T2 (tr) Yeni oligosakkaritler, bunların hazırlanması ve bunları içeren ilaç bileşimleri
HUP9600256A2 (en) Substituted diphenyl-sulfonamide endothelin antagonists, pharmaceutical compositions containing the same and their medical uses
DE69112735T2 (de) Stabilisierte Monomerenzusammensetzungen.
EP0610519A4 (en) Anti-hiv drug.
SE0004054D0 (sv) N-type calcium channel antagonists for the treatment of pain
NL9101936A (nl) Polymeermengsel en daaruit gevormde voorwerpen.
ATE160573T1 (de) 1,3.5 (10) - estratriene derivate mit oraler wirkung
HUP9900504A2 (en) Use of insect pheromones for producing pharmaceutical compositions having antiglucocorticoid effect
DE69108020T2 (de) Polymerzusammensetzung, und daraus hergestellte Formkörper.
BR9201398A (pt) Emprego de oligouretanas com pesos moleculares de 5.000 ate 50.000
IT9048066A0 (it) 2- amminotetraline-6, 7-sostituite attive come immunomodulanti e composizioni farmaceutiche che le contengono.
DE3279669D1 (en) Polymer stabilising compositions, polymers stabilised therewith and shaped articles formed from such polymers
DE69108626T2 (de) Stabilisierte Monomerenzusammensetzungen.
SE0004055D0 (sv) N-type calcium channel antagonists for the treatment of pain
EP0548376A4 (pt)
EP0729950A4 (en) ANTI-HIV MEDICINAL PRODUCTS
FR2715653B1 (fr) Agent inifer en copolymérisation radicalaire, son procédé de préparation, procédé de copolymérisation correspondant et utilisation des copolymères obtenus par ce procédé.
ES1015643Y (es) Instalacion de dosificacion, mezcla, envasado y pesaje.
GR3018930T3 (en) Slow-release medicament containing a dihydropyridine derivate as a nanosol and its preparation.

Legal Events

Date Code Title Description
BB1A Laying open of patent application

Effective date: 19930331

FG3A Patent granted, date of granting

Effective date: 19990331

MM4A Annulment/lapse due to non-payment of fees, searched and examined patent

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 20090930